FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2010900002> ?p ?o ?g. }

• W2010900002 endingPage "350" @default.
• W2010900002 startingPage "345" @default.
• W2010900002 abstract "Purpose: Bisphosphonates have been reported to be effective in reducing bone pain and skeletal-related events associated with bone metastases in hormone-refractory prostate cancer (HRPC). However, whether bone resorption is reduced primarily by these particular drugs is difficult to evaluate because patients with HRPC are usually treated with secondary or tertiary hormonal manipulations including second-line antiandrogens, high-dose diethylstilbestrol, or low-dose dexamethasone therapies, some of which may also be effective. Thus, we assessed changes in the level of the carboxyterminal telopeptide of type-I collagen (ICTP), a bone resorption marker, before and after pamidronate administration in HRPC patients with increasing prostate-specific antigen (PSA) levels. Patients and Methods: Twenty-one HRPC patients with bone metastases and increasing PSA levels were intravenously treated with pamidronate at a dose of 30 mg either every 2 or every 4 weeks. Pamidronate administration was started immediately after confirmation of three consecutive increases in the PSA level. Results: In 14 patients (67%), the ICTP levels decreased after the administration of pamidronate, despite increasing PSA levels. In 7 of these cases, the ICTP levels were lower than those recorded for 6 months or longer before the start of pamidronate administration. The characteristics of the responders were compared with those of the non-responders. Conclusion: In 67% of the HRPC patients with increasing PSA levels, pamidronate reduced the accelerated turnover of bone metabolism caused by metastases of prostate cancer." @default.
• W2010900002 created "2016-06-24" @default.
• W2010900002 creator A5000880725 @default.
• W2010900002 creator A5001730366 @default.
• W2010900002 creator A5005268331 @default.
• W2010900002 creator A5009694594 @default.
• W2010900002 creator A5009750476 @default.
• W2010900002 creator A5023252826 @default.
• W2010900002 creator A5027578308 @default.
• W2010900002 creator A5033405660 @default.
• W2010900002 creator A5035843311 @default.
• W2010900002 creator A5038598033 @default.
• W2010900002 creator A5084387565 @default.
• W2010900002 creator A5090278955 @default.
• W2010900002 date "2007-01-01" @default.
• W2010900002 modified "2023-09-23" @default.
• W2010900002 title "Palliative Treatment of Bone Metastases in Hormone-Refractory Prostate Cancer: Effects of Pamidronate on the Carboxyterminal Telopeptide of Type-I Collagen Level in Patients with Increasing Prostate-Specific Antigen Levels" @default.
• W2010900002 cites W1948383940 @default.
• W2010900002 cites W2007782037 @default.
• W2010900002 cites W2027602629 @default.
• W2010900002 cites W2039501050 @default.
• W2010900002 cites W2040618631 @default.
• W2010900002 cites W2040878961 @default.
• W2010900002 cites W2046750802 @default.
• W2010900002 cites W2065185355 @default.
• W2010900002 cites W2076262158 @default.
• W2010900002 cites W2078396840 @default.
• W2010900002 cites W2078814775 @default.
• W2010900002 cites W2079397016 @default.
• W2010900002 cites W2103009146 @default.
• W2010900002 cites W2115335453 @default.
• W2010900002 cites W2121436732 @default.
• W2010900002 cites W2123617018 @default.
• W2010900002 cites W2314428698 @default.
• W2010900002 cites W2316096113 @default.
• W2010900002 cites W2607028219 @default.
• W2010900002 cites W4328001230 @default.
• W2010900002 doi "https://doi.org/10.1159/000100840" @default.
• W2010900002 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17495494" @default.
• W2010900002 hasPublicationYear "2007" @default.
• W2010900002 type Work @default.
• W2010900002 sameAs 2010900002 @default.
• W2010900002 citedByCount "1" @default.
• W2010900002 countsByYear W20109000022016 @default.
• W2010900002 crossrefType "journal-article" @default.
• W2010900002 hasAuthorship W2010900002A5000880725 @default.
• W2010900002 hasAuthorship W2010900002A5001730366 @default.
• W2010900002 hasAuthorship W2010900002A5005268331 @default.
• W2010900002 hasAuthorship W2010900002A5009694594 @default.
• W2010900002 hasAuthorship W2010900002A5009750476 @default.
• W2010900002 hasAuthorship W2010900002A5023252826 @default.
• W2010900002 hasAuthorship W2010900002A5027578308 @default.
• W2010900002 hasAuthorship W2010900002A5033405660 @default.
• W2010900002 hasAuthorship W2010900002A5035843311 @default.
• W2010900002 hasAuthorship W2010900002A5038598033 @default.
• W2010900002 hasAuthorship W2010900002A5084387565 @default.
• W2010900002 hasAuthorship W2010900002A5090278955 @default.
• W2010900002 hasConcept C121608353 @default.
• W2010900002 hasConcept C125870589 @default.
• W2010900002 hasConcept C126322002 @default.
• W2010900002 hasConcept C126894567 @default.
• W2010900002 hasConcept C131075544 @default.
• W2010900002 hasConcept C134018914 @default.
• W2010900002 hasConcept C160160445 @default.
• W2010900002 hasConcept C170033053 @default.
• W2010900002 hasConcept C181199279 @default.
• W2010900002 hasConcept C185592680 @default.
• W2010900002 hasConcept C2776235491 @default.
• W2010900002 hasConcept C2776541429 @default.
• W2010900002 hasConcept C2777251235 @default.
• W2010900002 hasConcept C2777783956 @default.
• W2010900002 hasConcept C2780192828 @default.
• W2010900002 hasConcept C2781406297 @default.
• W2010900002 hasConcept C55493867 @default.
• W2010900002 hasConcept C673006 @default.
• W2010900002 hasConcept C71924100 @default.
• W2010900002 hasConceptScore W2010900002C121608353 @default.
• W2010900002 hasConceptScore W2010900002C125870589 @default.
• W2010900002 hasConceptScore W2010900002C126322002 @default.
• W2010900002 hasConceptScore W2010900002C126894567 @default.
• W2010900002 hasConceptScore W2010900002C131075544 @default.
• W2010900002 hasConceptScore W2010900002C134018914 @default.
• W2010900002 hasConceptScore W2010900002C160160445 @default.
• W2010900002 hasConceptScore W2010900002C170033053 @default.
• W2010900002 hasConceptScore W2010900002C181199279 @default.
• W2010900002 hasConceptScore W2010900002C185592680 @default.
• W2010900002 hasConceptScore W2010900002C2776235491 @default.
• W2010900002 hasConceptScore W2010900002C2776541429 @default.
• W2010900002 hasConceptScore W2010900002C2777251235 @default.
• W2010900002 hasConceptScore W2010900002C2777783956 @default.
• W2010900002 hasConceptScore W2010900002C2780192828 @default.
• W2010900002 hasConceptScore W2010900002C2781406297 @default.
• W2010900002 hasConceptScore W2010900002C55493867 @default.
• W2010900002 hasConceptScore W2010900002C673006 @default.
• W2010900002 hasConceptScore W2010900002C71924100 @default.
• W2010900002 hasIssue "4" @default.
• W2010900002 hasLocation W20109000021 @default.
• W2010900002 hasLocation W20109000022 @default.

• next